Literature DB >> 18514404

Quantitative analysis of the 4977-bp common deletion of mitochondrial DNA in postmortem frontal cortex from patients with bipolar disorder and schizophrenia.

Satoshi Fuke1, Mizue Kametani, Tadafumi Kato.   

Abstract

Several reports have suggested a role for mitochondrial dysfunction in the pathophysiology of bipolar disorder and schizophrenia. We have focused on the relationship between deleted mitochondrial DNA (mtDNA) and bipolar disorder. To investigate this relationship, we developed a methodology for quantification of the common 4977-bp deletion of mtDNA based on real-time polymerase chain reaction with SYBR Green. In this study, we assessed accumulation of the common deletion in postmortem frontal cortex from 147 individuals (48 controls, 49 patients with bipolar disorder, 50 patients with schizophrenia). We demonstrated age-dependent accumulation of the common deletion of mtDNA (p=1.09E-10). Females showed significantly higher accumulation of the deletion than did males (p=0.002). There was no significant association between accumulation and the two studied major mental disorders in the frontal cortex (p>0.2). However, there was no statistically significant correlation between the common deletion and aging in female patients with bipolar disorder (p=0.133), and no significant sex difference in patients with bipolar disorder (p=0.509). These results indicate that aging and sex have effect on accumulation of the common deletion of mtDNA in the prefrontal cortex depending on the diagnosis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18514404     DOI: 10.1016/j.neulet.2008.05.009

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  12 in total

1.  The somatic common deletion in mitochondrial DNA is decreased in schizophrenia.

Authors:  Firoza Mamdani; Brandi Rollins; Ling Morgan; P Adolfo Sequeira; Marquis P Vawter
Journal:  Schizophr Res       Date:  2014-09-28       Impact factor: 4.939

2.  Mitochondrial Complex I Deficiency in Schizophrenia and Bipolar Disorder and Medication Influence.

Authors:  Brandi L Rollins; Ling Morgan; Brooke E Hjelm; Adolfo Sequeira; Alan F Schatzberg; Jack D Barchas; Francis S Lee; Rick M Myers; Stanley J Watson; Huda Akil; Steven G Potkin; William E Bunney; Marquis P Vawter
Journal:  Mol Neuropsychiatry       Date:  2017-11-30

Review 3.  Mitochondrial dysfunction and pathology in bipolar disorder and schizophrenia.

Authors:  Hayley B Clay; Stephanie Sillivan; Christine Konradi
Journal:  Int J Dev Neurosci       Date:  2010-09-15       Impact factor: 2.457

4.  Psychiatric involvement in adult patients with mitochondrial disease.

Authors:  Michelangelo Mancuso; Daniele Orsucci; Elena Caldarazzo Ienco; Eleonora Pini; Anna Choub; Gabriele Siciliano
Journal:  Neurol Sci       Date:  2011-12-23       Impact factor: 3.307

Review 5.  Impaired mitochondrial function in psychiatric disorders.

Authors:  Husseini Manji; Tadafumi Kato; Nicholas A Di Prospero; Seth Ness; M Flint Beal; Michael Krams; Guang Chen
Journal:  Nat Rev Neurosci       Date:  2012-04-18       Impact factor: 34.870

Review 6.  Targeting mitochondrially mediated plasticity to develop improved therapeutics for bipolar disorder.

Authors:  Rafael T de Sousa; Rodrigo Machado-Vieira; Carlos A Zarate; Husseini K Manji
Journal:  Expert Opin Ther Targets       Date:  2014-07-24       Impact factor: 6.902

7.  Mitochondrial mutations and polymorphisms in psychiatric disorders.

Authors:  Adolfo Sequeira; Maureen V Martin; Brandi Rollins; Emily A Moon; William E Bunney; Fabio Macciardi; Sara Lupoli; Erin N Smith; John Kelsoe; Christophe N Magnan; Mannis van Oven; Pierre Baldi; Douglas C Wallace; Marquis P Vawter
Journal:  Front Genet       Date:  2012-06-20       Impact factor: 4.599

8.  Mitochondrial dysfunction in schizophrenia: With a focus on postmortem studies.

Authors:  Rosalinda C Roberts
Journal:  Mitochondrion       Date:  2020-11-20       Impact factor: 4.160

Review 9.  The Role of Mitochondria in Mood Disorders: From Physiology to Pathophysiology and to Treatment.

Authors:  Anna Giménez-Palomo; Seetal Dodd; Gerard Anmella; Andre F Carvalho; Giselli Scaini; Joao Quevedo; Isabella Pacchiarotti; Eduard Vieta; Michael Berk
Journal:  Front Psychiatry       Date:  2021-07-06       Impact factor: 4.157

Review 10.  Mitochondrial dysfunction in psychiatric morbidity: current evidence and therapeutic prospects.

Authors:  Lilach Toker; Galila Agam
Journal:  Neuropsychiatr Dis Treat       Date:  2015-09-24       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.